BOSTON SCIENTIFIC CORP ·

BSX 8-K 2026-09-23

BOSTON SCIENTIFIC CORP (BSX) 8-K dated 2026-09-23 — accession 0000885725-26-000061. This URL is the filing, not the BSX hub.

BOSTON SCIENTIFIC CORP (BSX) is a medical devices company listed on US.

BOSTON SCIENTIFIC CORP filed a 8-K on 2026-09-23. Accession 0000885725-26-000061.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BSX revenue for 2025-12-31 was $20.07B. Net income was $2.89B. Revenue was up 19.9% from 2024-12-31 to 2025-12-31. BSX currently screens at market cap $71.81B and trailing P/E 20.2.

Not investment advice. The BSX SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr